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Abstract
Background: One mechanism that directs the action of the second messengers, cAMP and
diacylglycerol, is the compartmentalization of protein kinase A (PKA) and protein kinase C (PKC).
A-kinase anchoring proteins (AKAPs) can recruit both enzymes to specific subcellular locations via
interactions with the various isoforms of each family of kinases. We found previously that a new
class of AKAPs, dual-specific AKAPs, denoted D-AKAP1 and D-AKAP2, bind to RIα  in addition to
the RII subunits.
Results: Immunohistochemistry and confocal microscopy were used here to determine that D-
AKAP1 colocalizes with RIα  at the postsynaptic membrane of the vertebrate neuromuscular
junction (NMJ) and the adjacent muscle, but not in the presynaptic region. The labeling pattern for
RIα  and D-AKAP1 overlapped with mitochondrial staining in the muscle fibers, consistent with our
previous work showing D-AKAP1 association with mitochondria in cultured cells. The
immunoreactivity of D-AKAP2 was distinct from that of D-AKAP1. We also report here that even
though the PKA type II subunits (RIIα  and RIIβ ) are localized at the NMJ, their patterns are
distinctive and differ from the other R and D-AKAP patterns examined. PKCβ  appeared to
colocalize with the AKAP, gravin, at the postsynaptic membrane.
Conclusions: The kinases and AKAPs investigated have distinct patterns of colocalization, which
suggest a complex arrangement of signaling micro-environments. Because the labeling patterns for
RIα  and D-AKAP 1 are similar in the muscle fibers and at the postsynaptic membrane, it may be
that this AKAP anchors RIα  in these regions. Likewise, gravin may be an anchor of PKCβ  at the
NMJ.
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Background
The cell's response to hormones is a dynamic process
that requires the efficient transmission of signals from
the extracellular environment to specific intracellular
sites. For PKA and PKC, the primary signal is generated
at the plasma membrane and proceeds through interme-
diary G-proteins that stimulate adenylyl cyclase [1] or
phospholipases [2] to generate the second messengers
cAMP and diacylglycerol, respectively. The diffusion of
these soluble second messengers leads to the activation
of PKA and PKC at specific subcellular locations [3,4].
The two families of the regulatory subunits of PKA, RI
and RII, have distinct cAMP binding properties and
phosphorylation states [4,5]. Each family has two differ-
ent isoforms, a and (3, resulting in four distinct types,
RIα , RIβ , RIIα , RIIβ . The different R isoforms have dis-
tinct tissue and subcellular distributions suggesting that
they may be selectively targeted by scaffold proteins, e.g.,
AKAPs anchored through different anchoring proteins
[6,7]. PKC has at least 11 isoforms [8]. The physiological
role of the individual PKCs has not been elucidated be-
cause most cells express multiple isoforms having nearly
identical ligand binding properties and substrate specif-
icity. Compartmentation of PKC isoforms has been sug-
gested as a mechanism for targeting selectivity near their
physiological substrates [9,10]. Consistent with this
theme of selectivity, work with isoform-specific antibod-
ies demonstrated that PKC isoforms have distinct sub-
cellular locations [11].
It has been known for the past decade that compartmen-
talization of PKA can occur through association with A-
kinase anchoring proteins (AKAPs). This association en-
sures specificity in signal transduction by placing kinases
close to their appropriate substrates where they can
swiftly respond to second messengers [6]. Another ad-
vantage of compartmentation to specific subcellular lo-
cations is to restrict accessibility to certain substrates.
Selected AKAPs have been identified that can interact
with both PKA and PKC [12,13]. For example, it was
shown that AKAP 79 maintains PKA, PKC, and protein
phosphatase 2B at the postsynaptic density of mammali-
an synapses [14,12]. Likewise, gravin, a second PKA/PKC
anchoring protein, targets these kinases to the mem-
brane cytoskeleton [13]. AKAP79, gravin, and its mouse
homolog clone 72 thus belong to the recently identified
class of scaffolding proteins that coordinate multiple ki-
nase activity by bringing them to one site.
For PKA binding, it was thought for a long time that only
RII subunits bind to AKAPs. However, a new class of
AKAPs was discovered when two dual-specific AKAPs
(D-AKAP1 and D-AKAP2) were cloned using a fusion
protein of the RIα  as the bait in a yeast two-hybrid screen
[15,16]). Therefore, the contrasted distribution pattern
between RI and RII may in part be due to selective asso-
ciation with different compartmentalized pools of AKA-
Ps.
Only recently has the subcellular distribution of PKA at
neuromuscular junctions (NMJs) and the adjacent mus-
cle been systematically studied [17,18]. Imaizumi-Scher-
rer and colleagues demonstrated that RIα  is localized at
the NMJ [19], but whether RI associates with a D-AKAP
in this region of muscle is not known. However, a recent
study showing the colocalization of D-AKAP1 with RI at
the NMJ supports the prediction that localization of the
R subunit there requires interaction with an AKAP [17].
RII has been shown to be associated with mAKAP in
heart and skeletal muscle [20,21]; however, little is
known regarding the expression patterns of RII and
AKAPs in the perijunctional regions. More information
has accumulated concerning PKC expression associated
with the NMJ and skeletal muscle. PKCβ  was shown to
localize to the presynaptic terminals of NMJs [22,23],
whereas PKCθ  plays a postsynaptic role at the NMJ [24].
In skeletal muscle, PKCα  was found in human muscle
fibers [25] and with T-tubules in rabbit skeletal muscle
[26]. However, it is unknown whether tethering to a
PKC-anchoring protein mediates the localization to
these compartments.
The work reported here was undertaken to further un-
derstand the compartmentalization of PKA and PKC
through association with AKAPs. Because RIα  was ob-
served in close association with the NMJ postsynaptic
membrane [19], we probed for D-AKAP expression and
possible colocalization with this and other regulatory
subunits. We also investigated the distribution of gravin
at the NMJ because this AKAP is an autoantigen for
myasthenia gravis, a degenerative disease of the NMJ.
Results
Western blot assays confirmed that the antibodies used
are monospecific (fig. 1). The blots show that PKCα , the
major PKC isoform present in muscle, is not detected by
the PKCβ II antibody, and that there is little overlap be-
tween the specificities of the PKA regulatory subunit an-
tibodies. As with a previous report studying different
groups of skeletal muscle [18], the soluble fraction con-
tained most of the RIα . A band for RIIβ  was detected in
contrast to a report of no RIIβ  detection in soleus or ex-
tensor digitorum longus muscles [18], which might be
explained by the presence of nerve fibers or adipocytes
wherein RIIβ  is prevalent [27]. The blot for the affinity-
purified D-AKAP1 antibody is shown because the pro-
tein-A purified antibody displayed additional, unex-
plained bands; however, no difference in fluorescence
labeling was observed when using antibodies purified ei-
ther way.BMC Neuroscience 2001, 2:17 http://www.biomedcentral.com/1471-2202/2/17
A previous report using immunofluorescence demon-
strated colocalization of RIα  with the nicotinic acetylcho-
line receptor (nAChR) at the NMJ postsynaptic
membrane [19]. We used immunohistochemistry cou-
pled with confocal microscopy to acquire detailed infor-
mation as to the intracellular localization of D-AKAP1 in
the several regions of the NMJ and adjacent intercostal
muscle to compare with that of RIα . Rhodamine-conju-
gated α -bungarotoxin was used to delineate the postsyn-
aptic membrane of the NMJ because it binds tightly to
the nAChR found at this membrane. Because D-AKAP1
was shown to associate with mitochondria [28], double-
labeling with markers for this organelle, either anti-lipo-
ic acid or anti-cytochrome c, was used to examine wheth-
er RIα  or D-AKAP1 are associated with mitochondria in
the NMJ.
We found partial overlap of the RIα  label with synapto-
physin, which labels presynaptic vesicles (fig. 2a). Im-
portantly, RIα  was observed to be concentrated in other
vicinities of the presynapse as well. In the postsynaptic
region, RIα  immunoreactivity showed partial overlap
with the mitochondrial marker (lipoic acid); overlap with
mitochondria in muscle fibers was also observed (fig.
2b). In muscle, labeling of the I-band by anti RIα  was
dominant. The I-band contains actin and is where mito-
chondria are located, but has no myosin.
The distribution of D-AKAP1 at the postsynaptic NMJ
and the adjacent muscle is similar to that of RIα , al-
though there is no codistribution at the presynaptic re-
gion between these two labels (fig. 3a). D-AKAP1 is
expressed in both NMJ and intercostal muscle. D-AKAP1
codistribution with cytochrome c (mitochondrial mark-
er) is significant (fig. 3a), but not as pronounced as the
RIIα  association with mitochondria (compare with fig.
5). We observed an enrichment of D-AKAP1 at the post-
synaptic membrane, as shown by codistribution with
nAChR (fig. 3b). As with RIα , labeling of the actin region
by anti-D-AKAP1 was dominant (fig. 3a, 3c). Because the
Figure 1
Western blot showing specificity of antibodies used for immunofluorescence. A. Gravin was detected using affinity-purified
antibodies raised against residues 1130–1780 of the recombinant protein. HeLa cell lysates were incubated with 15 µg of anti-
gravin (Lysate) or 15 µg of preimmune IgG (Pre). B. and C. Triton X-100 soluble supernatant (Sup) and insoluble pellet (Pel)
of rat intercostal muscle homogenate were subjected to polyacrylamide gel electrophoresis, transferred to membrane, and
immunoblotted to detect the protein of interest. Molecular weight markers are shown with arrowheads. Of particular impor-
tance are the blots showing that PKC α  the major PKC isoform present in muscle, is not detected with the PKC β II antibody,
and that there is little overlap between the specificities of the PKA regulatory domain antibodies.BMC Neuroscience 2001, 2:17 http://www.biomedcentral.com/1471-2202/2/17
labeling patterns for RIα  and D-AKAP1 appear similar in
the muscle fibers and at the postsynaptic membrane, D-
AKAP1 may anchor RIα  in these regions, which further
supports the cloning and biochemical evidence of inter-
action between these proteins [15,28]. Phalloidin was
used as a positive control for the actin region of muscle
fibers (fig. 3c). The no-primary control was clean (fig.
3d). Because the antibodies to D-AKAP1 and RIα  were
produced in rabbit and mouse, respectively, double-la-
beling confocal experiments could be performed with
these antibodies on the same tissue slice in order to test
for colocalization. The same applies for anti-RIIα  and
anti-RIIβ . We found that the labeling patterns for these
two antibodies in muscle tissue counterstained with bun-
garotoxin and anti-D-AKAP1 (data not shown) was not
modified from that found when counterstained with
bungarotoxin and a mitochondrial marker (see below),
indicating partial colocalization of D-AKAP1 with RIIα
but, little if any overlap with RIIβ . In contrast, the RIα  la-
beling was invariably almost completely abolished when
counterstained with bungarotoxin and anti-D-AKAP1 in
multiple experiments (data not shown). This suggests to
us that anti-D-AKAP1 may be occluding RIα  bound to D-
AKAP1 to the extent that anti-RIα  has little access to its
antigen.
As shown in figure 4, RIIβ  is found in the postsynaptic
region of the NMJ and did not precisely overlap with the
α -bungarotoxin label but instead encompassed a broad-
er area of this region. RIIβ  immunoreactivity appeared to
be punctate in the cytosol, yet contrasted with the punc-
tate distribution of mitochondria. The presence of labe-
ling at the NMJ is consistent with the prevalence of RII
in neuronal tissue [27]. The lack of staining in the muscle
fibers is in agreement with the report that RIIβ  did not
show significant hybridization with skeletal muscle [19].
Triple-labeling immunofluorescent staining patterns
(fig. 5) suggests that RIIα  is concentrated in the postsyn-
aptic vicinity of the NMJ but is not colocalized with the
nAChR. RIIα  immunoreactivity exhibited significant
overlap with mitochondria in the postsynaptic region of
the NMJ and with mitochondria in skeletal muscle fib-
ers. Labeling of the I-band was dominant. Interestingly,
intense immunoreactivity was found to be consistently
localized with the z-line. Of the 7 kinase and AKAP labe-
ling patterns shown in this paper, RIIα  is the only one
that strongly associates with the z-line (contrast with the
phalloidin labeling shown in fig. 2c).
The labeling pattern of D-AKAP2 (fig. 6) differs from that
of D-AKAP1. Even though the striated labeling in the
muscle fibers appears similar to the striations noted for
D-AKAP1 and RIα  and is where actin is prevalent, the
overlap with the mitochondrial marker (cytochrome c) is
poor, in contrast with observations of close overlap in
cells [29]. In the NMJ, the D-AKAP2 pattern is rather
diffuse, being present in both postsynaptic and presyn-
aptic vicinities, and appears dissimilar to the mitochon-
drial pattern.
Figure 2
RIα  labeling of the NMJ and adjacent muscle. Individual opti-
cal sections from separate z-series were chosen after deblur-
ring that most completely shows the postsynaptic membrane
topography in order to demarcate presynaptic from postsyn-
aptic regions. (a) Partial overlap occurs between RIα  and
synaptophysin, which labels presynaptic vesicles. Overlap is
also seen with bungarotoxin, although it is not prominent,
scale bar = 10 µm.  (b) RIα  overlaps the mitochondrial
marker in the postsynaptic region, as well as mitochondria in
the actin region of muscle fibers. Motor endplates were iden-
tified by labeling the nAChR using rhodamine-conjugated α -
bungarotoxin. Anti-lipoic acid marks mitochondria only. scale
bar = 10 µm.BMC Neuroscience 2001, 2:17 http://www.biomedcentral.com/1471-2202/2/17
Intense PKCβ  immunoreactivity was found in both post-
synaptic and presynaptic regions (fig. 7), consistent with
enhanced PKCα  and PKCθ  labeling in the NMJ [24].
Over a background of more diffuse staining, two stronger
bands can be observed. One band codistributes with
nAChR. The other band is in the presynaptic region and
parallels the nAChR band. In addition to these bands,
there is strong immunoreactivity in other areas of the pr-
esynapse. The labeling pattern of PKCβ  is sufficiently dif-
ferent from that of the mitochondrial label to indicate
that there is no association with this organelle in either
the NMJ or muscle fibers. PKCβ  labeling in the muscle
fibers is faint, which corroborates the report that PKCα
and PKCθ  are the predominant PKC isoforms in skeletal
muscle [24], with PKCθ  being more abundant in the
Figure 3
Confocal microscope images of D-AKAP1 labeled NMJ in
adult rat intercostal muscle. Anti-cytochrome c marks mito-
chondria and bungarotoxin labels the nAChR. (a) Distribu-
tion of D-AKAP1 at the NMJ and adjacent muscle. D-AKAP1
codistributes with cytochrome c in the actin region of the
intercostal muscle and the postsynaptic region of the NMJ.
(b) D-AKAP1 is enriched at the postsynaptic membrane, as
shown by codistribution with nAChR. scale bar = 10 µm for
both (a) and (b). (c) Double-labeling of phalloidin, which
binds to F-actin, and D-AKAP1. Phalloidin demarcates the
actin region and is used as a positive control for this
region,(d) No primary control. Fluorophore-conjugated sec-
ondary antibodies show that very low background from non-
specific labeling comes from these antibodies. Bungarotoxin-
TRITC was used to find the NMJs in the negative controls,
scale bar = 10 µm for both (c) and (d).
Figure 4
Confocal images of immunofluorescent staining in and
around an NMJ showing RIIβ , lipoic acid, and bungarotoxin
patterns separately and in composite overlay. An individual
section from a deblurred z-series shows RIIβ  immunoreactiv-
ity only in the postsynaptic region having little overlap with
the mitochondrial marker, scale bar = 10 µm.
Figure 5
Triple-labeling immunofluorescent staining patterns show
RIIα , lipoic acid, and bungarotoxin separately and in compos-
ite overlay. RIIα  immunoreactivity overlapped significantly
with mitochondria, present along I-bands and in striations
perpendicular to these bands. Within the muscle fibers, RIIα
is seen to label the z-line, an area that phalloidin also labels
(see fig. 1), in addition to the I-band. scale bar = 10 µm.BMC Neuroscience 2001, 2:17 http://www.biomedcentral.com/1471-2202/2/17
membrane fraction of muscle and PKCα  being more
abundant in the cytosolic fraction.
As with PKCβ , gravin codistributes with nAChR (fig. 8).
Immunoreactivity is predominantly in the postsynaptic
region and doesn't overlap particularly well with the mi-
tochondrial marker. The strongest labeling is at the plas-
ma membrane. This labeling is consistent with the report
that gravin possesses several targeting motifs that direct
it to the membrane-cytoskeleton [13]. In the muscle fib-
ers, striations of staining are noticeable. Even though
there is partial overlap of these striations with those typ-
ical of mitochondria (labeled with cytochrome c), the
staining occurs where actin is prevalent. Because gravin
has a putative actin-binding domain, it is likely that the
association is with actin. Tables 1 and 2 summarize the
compartmental localization and mitochondrial associa-
tion in the NMJ and intercostal muscle of the several
AKAPs and kinases studied based on the immunofluo-
rescence work reported here.
Discussion
The work presented here adds to the emerging evidence
that PKA and PKC signaling at the NMJ and adjacent in-
tercostal muscle is compartmentalized. Differential com-
partmentation of these signaling molecules in cells and
tissues is being recognized as a mechanism to regulate
their specificity [reviewed recently by [6]]. A Kinase An-
choring Proteins (AKAPs) can direct their subcellular lo-
calization by binding directly to regulatory subunits of
PKA or to the catalytic core of PKC. Many AKAPs have
been identified, although information about their sub-
cellular distribution in different tissues is largely lacking.
Because we produced antibodies to two novel dual-spe-
cific AKAPs (D-AKAP1 and D-AKAP2), and gravin, we
were uniquely positioned to use immunofluorescence to
investigate their possible roles in kinase signaling in and
around the NMJ. Our interest in PKA and PKC activity in
the NMJ derives from: (1) a report that RIα  not only is
enriched there, but also appears to be tethered to the
postsynaptic membrane [19], (2) the rich literature de-
scribing selective PKC isoform activity and functional
compartmentalization in the NMJ and skeletal muscle,
(3) our discoveries that D-AKAP1 and D-AKAP2 bind to
and appear to colocalize with RIα , and often mitochon-
Figure 6
Distribution of D-AKAP2 at the NMJ and adjacent muscle.
D-AKAP2 labeling is diffuse in both pre-and postsynaptic
regions of the NMJ. In muscle, D-AKAP2 labeling is in the
actin region, but does not colocalize well with mitochondria.
Indeed, the strongest labeling is perpendicular to the mito-
chondrial striations. scale bar = 10 µm.
Figure 7
PKCβ  labeling of the NMJ. Over a background of more dif-
fuse staining, two stronger bands are seen (double arrows).
One band codistributes with nAChR. The other band, found
in the presynaptic region, parallels the nAChR band and may
be labeling the presynaptic membrane. In addition to these
bands, there are strong pockets of immunoreactivity in other
areas of the presynapse (arrowheads). There appears to be
no association of PKCβ  with the mitochondrial label. PKCβ
labeling in the muscle fibers is faint, scale bar = 10 µm.BMC Neuroscience 2001, 2:17 http://www.biomedcentral.com/1471-2202/2/17
dria [15,16,28]; and (4) our finding that gravin binds to
both PKA and PKC [13].
We found that D-AKAP1 appears to colocalize with RIα
at the postsynaptic membrane of the NMJ, which houses
the nAChR, but not in the presynaptic region. This obser-
vation is supported by previous work that demonstrated
RIα  codistribution with nAChR [19] and D-AKAP1 [17]
suggesting that this AKAP is the anchoring protein re-
cruiting RIα  to this membrane. This putative association
is strengthened by finding for the first time that targeting
of RIα  requires the AKAP binding surface [17]. Yotiao is
another AKAP enriched at the NMJ, but appears to bind
only RII [30]. PKA phosphorylates the nAChR when
stimulated at the synapse by the neuropeptide CGRP and
by adenosine from muscle responding to acetylcholine
[reviewed by [31]]. This phosphorylation may regulate
the degradation of the nAChR [32]. Consistent with the
action at the presynapse, it was shown that PKA facilita-
tion of acetylcholine release is dependent on nerve end-
plate calcium concentration [33]. Based on our
observation of colocalization with synaptophysin at pre-
synaptic vesicles, RIα  may be the isotype that influences
this release of neurotransmitter.
We found that RIα  occupies the same region as mito-
chondria in intercostal muscle. The presence of RIα  in
soleus muscle was shown with Western blots by Hoover
and coworkers [18], but was not seen with immunofluo-
rescence of tibialis anterior muscle [17,19]. Reinitz and
coworkers [34] provided evidence suggesting that RIα
associates with membrane fractions in cardiac muscle
when it is not associated with the catalytic subunit. The
same may be true for intercostal muscle, in which case,
association with the sarcolemma, mitochondria or other
organelles is possible. Furthermore, RIα  was shown to
bind to cytochrome c oxidase subunit Vb (a mitochondri-
al inner membrane protein), which faces the matrix, in a
cAMP-dependent manner [35]. How RIα  passes across
the mitochondrial inner membrane is not known. Previ-
ously, we observed that D-AKAP1 mRNA and protein ex-
pressions are high in muscle [15]. In situ hybridization
showed consistency of D-AKAP1 and RIα  staining in
tongue muscle, indicating that in vitro association can
indeed predict in situ interaction for these molecules.
Consistent with the observed mitochondrial staining by
anti-D-AKAP1, it was shown previously that one of the
two alternative NH2-terminal motifs of this AKAP is nec-
essary and sufficient for targeting to mitochondria [28].
Interestingly, another AKAP governs voltage-dependent
potentiation of L-type calcium channels through anchor-
ing of PKA in transverse tubules [36]. Because this po-
tentiation is not dependent on RIIα , it is thought that
RIα  is capable of this AKAP-directed modulation of cal-
cium channel activity [37].
The labeling pattern of D-AKAP2 is diffuse in the NMJ,
yet localized to the actin region in muscle. In our previ-
ous immunofluorescence work examining D-AKAP2
subcellular localization, the protein displayed a diffuse
background in addition to mitochondrial staining [29]. It
was thought that the combination of specific and diffuse
labeling indicated the presence of more than one pool of
D-AKAP2 inside the cells examined. Whereas, D-AKAP1
appears to colocalize with mitochondria in muscle fibers,
D-AKAP2 shows no such association. This observation is
not surprising because it is not expected that their tar-
gets need to be in the same organelle or even subcellular
region. Whether D-AKAP2 binds specifically to actin re-
mains to be determined.
RIIα  localized quite well to mitochondria in both NMJ
and muscle regions. PKA association with mitochondria
has been well documented [38–42]. In mammalian
sperm, it was found that nearly all RII-specific labeling
was with mitochondria [43]. Furthermore, in bovine
Figure 8
Gravin labeling of the NMJ and intercostal muscle. Labeling is
strongest at the plasma membrane-cytoskeleton (arrow).
Codistribution is also found with nAChR at the postsynaptic
membrane. Labeling in the muscle is in the actin-rich region,
scale bar = 10 µm.BMC Neuroscience 2001, 2:17 http://www.biomedcentral.com/1471-2202/2/17
heart, PKA activity was detected in the matrix or the ma-
trix side of the mitochondrial inner membrane [44,45].
However, the work of Halestrap and coworkers provided
little evidence for intramitochondrial protein phosphor-
ylation by PKA, but gave some evidence for outer mem-
brane phosphorylation, both integral and loosely bound
proteins [46–48]. The localization of RIIα  to the postsy-
naptic region beyond the postsynaptic membrane is con-
sistent with part of the immunostaining of NMJs in the
soleus muscle [18], yet differs in part because there is no
overlap with the bungarotoxin label; however, this is in
agreement with another study [17].
PKCβ  colocalizes with gravin at the postsynaptic mem-
brane where the gravin staining is strongest. PKC has
been suggested to play a role in synapse stability and sig-
nal transduction at the NMJ [24]. When calcium influx
through the nAChR occurs, acetylcholine appears to ac-
tivate PKC phosphorylation of this receptor [reviewed by
[31]]. Phorbol ester activation of PKC causes loss of syn-
apses and nAChR [49]. Because the presynaptic PKCβ
fluorescence band parallels the nAChR band (see fig. 7),
it may be labeling the presynaptic membrane, consistent
with reports of PKCβ  localization to the presynaptic ter-
minals of NMJs [22,23]. PKCβ  initially associates with
the cytoskeleton [50]. Phosphorylation at two places on
the kinase core is required first to activate PKC, and sec-
ond to release it from its cytoskeletal anchorage. Our im-
munofluorescence results may be the visualization of two
pools of PKCβ . The observed bands may represent kinase
anchored directly to the cytoskeleton, perhaps on the pr-
esynaptic side, where little gravin staining was found, or
anchored to gravin, perhaps on the postsynaptic side.
The more diffuse staining found in both pre- and postsy-
naptic regions may represent released, hence activated
kinase.
As with PKCβ , gravin was seen to be directed to the post-
synaptic membrane. Strong labeling was also seen at the
plasma membrane-cytoskeleton (see fig. 8), consistent
with the report of Nauert and coworkers [13]. Interest-
ingly, a homology search of a database revealed a
MARCKS homology actin-binding domain in gravin. In
addition to acting as a scaffolding protein for kinases and
phosphatases, gravin forms a dynamic complex with
beta-adrenergic receptors [51]. The same report also
showed that the association of beta-adrenergic receptors
with PKA could be blocked by the Ht31 peptide, which
blocks AKAP-kinase binding. In addition to a PKC bind-
ing site, gravin contains a PKA binding site. Hence, the
beta-adrenergic receptor may be tethered to PKA via
gravin. PKC may bind to this anchoring protein through
displacement of the pseudosubstrate, thus inhibiting the
kinase activity, by analogy with a functionally similar
scaffolding AKAP, AKAP79 [52].
Conclusions
The distinctive labeling patterns of each of the seven ki-
nase and anchoring antibodies investigated argues for
the existence of microdomains of signaling pathways. It
appears that several AKAPs may be in close proximity;
yet, it still needs to be determined if waves of cAMP
would turn on signals in a local or global way. Moreover,
the signals that cells in tissues receive from the sur-
rounding matrix may provide a different micro-environ-
Table 1: Labeling inside the NMJ
Post-synaptic Pre-synaptic Mitochondrial
RIα -weak overlap with bungarotoxin RIα -overlap with synaptophysin RIα  partial
D-AKAP2 D-AKAP2 D-AKAP1
PKCβ -overlap with bungarotoxin PKCβ RIIα
Gravin-overlap with bungarotoxin
D-AKAP1-overlap with bungarotoxin
RIIβ -no overlap with bungarotoxin
RIIα -no overlap with bungarotoxin
Table 2: Labeling inside the muscle
Actin Region*
I-band + z-line No labeling Mitochondrial 
region#
RIα RIIα RIIβ RIα
D-AKAP1 PKCβ D-AKAP1
D-AKAP2 RIIα
gravin
*I-band and the portion of the A-band where actin and myosin overlap 
# Overlap with a mitochondrial marker, either anti-lipoic acid or anti-
cytochrome cBMC Neuroscience 2001, 2:17 http://www.biomedcentral.com/1471-2202/2/17
ment of kinase anchoring from that of cultured cells. An
example is the association of D-AKAP2 with mitochon-
dria in cultured myocytes [29] that is not present in mus-
cle tissue (fig. 6).
Materials and Methods
Materials
Mouse anti-PKA RIα , mouse anti-PKA RIIβ , and mouse
anti-PKA RIIα  were purchased from Transduction Labo-
ratories. Mouse anti-cytochrome c was purchased from
PharMingen. Rabbit anti-PKC bII was purchased from
Panvera. Rabbit anti-D-AKAP1 [28], rabbit anti-D-
AKAP2 [29], and rabbit anti-gravin [13] were previously
detailed. Rabbit anti-PKA RIα  was prepared by synthe-
sizing the N-terminal 18 residues of human RIα  protein
and conjugating this peptide (MESGSTAASEE-
ARSLREC) to keyhole limpet haemocyanin (KLH) via
the bifunctional reagent, m-maleimidobenzoyl-N-hy-
droxysuccinimide ester (MES). The KLH-RIα  18 mer
was sent to Cocalico Biological Co. for polyclonal anti-
body production in rabbits using established procedures.
Rabbit anti-lipoic acid cofactor was produced as de-
scribed by Humphries and Szweda [53]. Phalloidin-
rhodamine binds to F-actin and was obtained from Mo-
lecular Probes. Fluorescein-labeled donkey anti-rabbit
IgG and Cy5-labeled donkey anti-mouse IgG were pur-
chased from Jackson ImmunoResearch. TRITC(rhod-
amine)-α -bungarotoxin was purchased from Molecular
Probes, Inc.
Western Blots
For anti-gravin. Western blots were performed as de-
scribed previously [13]. For all other antibodies, rat in-
tercostal muscle was excised and homogenized in 20 mM
HEPES, pH 7.4, with 20 mM Nad, 5 mM EDTA/EGTA,
0.5% Triton X-100, ImM DTT and protease inhibitors on
ice. The homogenate was centrifuged at 14,000 ×  g, for
30 min at 4°C; the soluble supernatant and insoluble pel-
let were each mixed with 4×  SDS-PAGE sample buffer.
These samples were separated by SDS-PAGE, electro-
phoretically transferred to polyvinylidene difluoride
membrane, and blocked with 5% milk in PBS-T. Mem-
branes were then probed with antibodies at ten-fold
higher dilution than used for immunofluorescence for
one hour, followed by one hour incubation with peroxi-
dase conjugated secondary antibodies and detection
with chemiluminescence. Western blots were repeated at
least once to confirm results.
Immunofluorescence
Sprague-Dawley male rats weighing 100 g (about 4
weeks old) were anesthetized with the general anesthet-
ic, nembutol. These rats were then whole-body, per-
fusion-fixed with 4% paraformaldehyde and 0.1%
glutaraldehyde in a PBS solution, after perfusion with
Ringers solution to clear the blood. Intercostal muscle
was quickly extracted and immersion-fixed for 1 h on ice.
Small strips of muscle were cut that were suitable for
confocal microscopy. All of the following steps were per-
formed on ice or at 4°C. Strips of intercostal muscle were
rinsed in PBS with 0.4 mg/ml glycine (to quench the al-
dehydes) for 5 min, and permeabilized with blocking
buffer for 20 min (0.2% triton X-100, 1% normal donkey
serum, 1% cold-water fish gelatin and 1% BSA in PBS-
glycine). Primary and secondary antibodies were diluted
in working buffer (blocking buffer diluted 10×  with PBS).
The tissue was stained with a mixture of 2 primary anti-
bodies – a kinase or AKAP, and a mitochondrial marker
(either anti-cytochrome c or anti-lipoic acid cofactor) –
overnight at 4°C. The tissue was washed extensively with
working buffer after the overnight incubation. Secondary
antibodies and bungarotoxin were added for 1 hour at
4°C in the dark. Afterwards, the tissue was again washed
extensively with working buffer before mounting on
glass slides and cover-slipped with gelvatol (anti-fade
medium). The slides were stored in a refrigerator until
imaged. A no-primary control was used to select condi-
tions that blocked the nonspecific labeling of secondary
antibodies. Laser-scanning confocal microscopy was
performed as described previously [28]. Experiments
were repeated at least once to confirm the fluorescence
patterns. Each fluorophore was recorded separately us-
ing narrow-band filters centered at 522 (fluorescein),
605 (rhodamine), and 680 nm (cy5). Z-series were re-
corded with each fluorophore with x,y pixel size of 0.05
microns and z-step of 0.18 microns. Each series com-
prised between 20 and 50 optical sections. Z-series were
deblurred using a blind deconvolution algorithm from
Autoquant.
List of abbreviations
AKAP – A kinase anchoring protein
D-AKAP – dual RI and RII-specific AKAP
KLH – keyhole limpet haemocyanin
MES – m-maleimidobenzoyl-N-hydroxysuccinimide es-
ter
nAChR – nicotinic acetylcholine receptor
NMJ – neuromuscular junction
PKA – protein kinase A
PKC – protein kinase C
RIα  – PKA regulatory type I subunit alphaBMC Neuroscience 2001, 2:17 http://www.biomedcentral.com/1471-2202/2/17
RIIα  – PKA regulatory type II subunit alpha
RIIβ  – PKA regulatory type II subunit beta
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